Piramal Pharma share price
You have to be logged in to add this to Watchlist.- ₹176.50(-0.20%)May 13, 2026 15:23:01 PM IST
- NSE
- BSE
- Vol : 3.40 M (NSE + BSE)Last 20 day avg : 10.21 M
Piramal Pharma is trading -0.20% lower at Rs 176.50 as compared to its last closing price. Piramal Pharma has been trading in the price range of 181.40 & 176.05. Piramal Pharma has given 2.53% in this year & 10.41% in the last 5 days. There are 9 analysts who have initiated coverage on Piramal Pharma. There are 5 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of -8.83 Crores in its last quarter.Listed peers of Piramal Pharma include Divi's Laboratories (2.20%), Sun Pharmaceutical Industries (-1.35%), Dr Reddy's Laboratories (-0.52%).The Mutual Fund holding in Piramal Pharma was at 14.12% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Piramal Pharma was at 30.17% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 13, 2026, 09:53 AM UTC
- BetaHigh volatility1.49Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.70The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values2.99The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bullish | 6,790.00 | 2.20 | 1,80,418.83 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,820.90 | -1.35 | 4,36,884.61 | 36.24 | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Neutral | 1,263.45 | -0.52 | 1,05,582.81 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Bearish | 1,325.45 | 2.59 | 1,06,807.15 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 4,293.00 | -1.99 | 1,45,288.79 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-04-28 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-07-28 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE0DK501011
- BSE Code543635
- NSE CodePPLPHARMA
Piramal Pharma is trading at 176.50 as on Wed May 13 2026 09:53:01. This is -0.20% lower as compared to its previous closing price of 176.85.
The market capitalization of Piramal Pharma is 23499.76 Cr as on Wed May 13 2026 09:53:01.
The average broker rating on Piramal Pharma is Strong Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 4 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Piramal Pharma is 226.00 whereas the 52 wk low is 132.50
Piramal Pharma can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 23.87
- Dividend Yield: 0.00%
- D/E ratio: 0.70
Piramal Pharma reported a net profit of -325.94 Cr in 2026.
The Mutual Fund Shareholding was 14.12% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Piramal Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.